AR072399A1 - Metodos y dispositivos oftalmicos utilizados en el tratamiento de alergias oculares - Google Patents
Metodos y dispositivos oftalmicos utilizados en el tratamiento de alergias ocularesInfo
- Publication number
- AR072399A1 AR072399A1 ARP090102409A ARP090102409A AR072399A1 AR 072399 A1 AR072399 A1 AR 072399A1 AR P090102409 A ARP090102409 A AR P090102409A AR P090102409 A ARP090102409 A AR P090102409A AR 072399 A1 AR072399 A1 AR 072399A1
- Authority
- AR
- Argentina
- Prior art keywords
- antiallergic agent
- ketotifen
- treatment
- effective amount
- minimum effective
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Ophthalmology & Optometry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Eyeglasses (AREA)
Abstract
Se divulgan dispositivos oftálmicos y métodos para su preparacion. Reivindicacion 1: Un método para la preparacion de un dispositivo oftálmico que comprende una cantidad eficaz mínima de un agente antialérgico, caracterizado porque comprende el tratamiento de un dispositivo oftálmico que comprende menos de aproximadamente una cantidad eficaz mínima de un agente antialérgico, con una solucion que comprende dicho agente antialérgico, donde la cantidad de dicho agente antialérgico en dicha solucion excede la cantidad eficaz mínima. Reivindicacion 2: El método de la reivindicacion 1, caracterizado porque el agente antialérgico se selecciona del grupo que consiste en azelastina, epinastina, cetotifeno, cetotifeno fumarato, nor-cetotifeno fumarato, olopatadina y sus mezclas. Reivindicacion 7: El método de la reivindicacion 1, caracterizado porque el dispositivo oftálmico es una lente de contacto blanda. Reivindicacion 26: El método de la reivindicacion 19, caracterizado porque el agente antialérgico es cetotifeno o sus sales aceptables para uso farmacéutico, la cantidad eficaz mínima de cetotifeno o sus sales aceptables para usa farmacéutico es alrededor de 9mg a alrededor de 40mg; y el dispositivo oftálmico es una lente de contacto blanda que comprende etafilcon A.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US7684708P | 2008-06-30 | 2008-06-30 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR072399A1 true AR072399A1 (es) | 2010-08-25 |
Family
ID=41328564
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP090102409A AR072399A1 (es) | 2008-06-30 | 2009-06-29 | Metodos y dispositivos oftalmicos utilizados en el tratamiento de alergias oculares |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20090324691A1 (es) |
| EP (1) | EP2317976A1 (es) |
| JP (1) | JP2011526805A (es) |
| KR (1) | KR20110028636A (es) |
| CN (1) | CN102137654A (es) |
| AR (1) | AR072399A1 (es) |
| AU (1) | AU2009265021A1 (es) |
| BR (1) | BRPI0913653A2 (es) |
| CA (1) | CA2729077A1 (es) |
| RU (1) | RU2011103173A (es) |
| TW (1) | TW201014593A (es) |
| WO (1) | WO2010002563A1 (es) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8758802B2 (en) * | 2009-12-14 | 2014-06-24 | University Of Massachusetts | Methods of inhibiting cataracts and presbyopia |
| TWI588560B (zh) | 2012-04-05 | 2017-06-21 | 布萊恩荷登視覺協會 | 用於屈光不正之鏡片、裝置、方法及系統 |
| US9201250B2 (en) | 2012-10-17 | 2015-12-01 | Brien Holden Vision Institute | Lenses, devices, methods and systems for refractive error |
| AU2013332247B2 (en) | 2012-10-17 | 2018-11-29 | Brien Holden Vision Institute Limited | Lenses, devices, methods and systems for refractive error |
| US9248928B2 (en) | 2012-12-21 | 2016-02-02 | Coopervision International Holding Company, Lp | Methods of manufacturing contact lenses for delivery of beneficial agents |
| PE20151747A1 (es) | 2013-03-14 | 2015-12-18 | Univ Massachusetts | Metodo para inhibir cataratas y presbicia |
| CA3004585A1 (en) | 2015-11-13 | 2017-05-18 | The University Of Massachusetts | Bifunctional molecules containing peg for use in inhibiting cataracts and presbyopia |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4998498A (en) * | 1989-07-07 | 1991-03-12 | Gallichan R. & Ass., Inc. | Knockdown sailboat |
| US5760100B1 (en) * | 1994-09-06 | 2000-11-14 | Ciba Vision Corp | Extended wear ophthalmic lens |
| TW585882B (en) * | 1995-04-04 | 2004-05-01 | Novartis Ag | A method of using a contact lens as an extended wear lens and a method of screening an ophthalmic lens for utility as an extended-wear lens |
| WO1997020852A1 (en) * | 1995-12-07 | 1997-06-12 | Bausch & Lomb Incorporated | Monomeric units useful for reducing the modulus of silicone hydrogels |
| US6822016B2 (en) * | 2001-09-10 | 2004-11-23 | Johnson & Johnson Vision Care, Inc. | Biomedical devices containing internal wetting agents |
| US6087415A (en) * | 1998-06-11 | 2000-07-11 | Johnson & Johnson Vision Care, Inc. | Biomedical devices with hydrophilic coatings |
| US6395756B2 (en) * | 1999-12-23 | 2002-05-28 | Novartis Ag | Use of ophthalmic agent |
| US20060100408A1 (en) * | 2002-03-11 | 2006-05-11 | Powell P M | Method for forming contact lenses comprising therapeutic agents |
| AU2007272706A1 (en) * | 2006-07-10 | 2008-01-17 | Johnson & Johnson Vision Care, Inc. | Packages for ophthalmic lenses containing pharmaceutical agents |
| HUE033597T2 (hu) * | 2006-09-29 | 2017-12-28 | Johnson & Johnson Vision Care | Eljárás allergia elleni szert tartalmazó szemészeti eszköz oxidációjának megelõzésére |
-
2009
- 2009-06-11 EP EP09774015A patent/EP2317976A1/en not_active Withdrawn
- 2009-06-11 WO PCT/US2009/046986 patent/WO2010002563A1/en active Application Filing
- 2009-06-11 RU RU2011103173/15A patent/RU2011103173A/ru not_active Application Discontinuation
- 2009-06-11 CN CN2009801349182A patent/CN102137654A/zh active Pending
- 2009-06-11 BR BRPI0913653A patent/BRPI0913653A2/pt not_active IP Right Cessation
- 2009-06-11 US US12/482,676 patent/US20090324691A1/en not_active Abandoned
- 2009-06-11 JP JP2011516424A patent/JP2011526805A/ja not_active Abandoned
- 2009-06-11 AU AU2009265021A patent/AU2009265021A1/en not_active Abandoned
- 2009-06-11 CA CA2729077A patent/CA2729077A1/en not_active Abandoned
- 2009-06-11 KR KR1020117002089A patent/KR20110028636A/ko not_active Application Discontinuation
- 2009-06-29 AR ARP090102409A patent/AR072399A1/es not_active Application Discontinuation
- 2009-06-29 TW TW098121753A patent/TW201014593A/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR20110028636A (ko) | 2011-03-21 |
| BRPI0913653A2 (pt) | 2015-10-20 |
| TW201014593A (en) | 2010-04-16 |
| WO2010002563A1 (en) | 2010-01-07 |
| JP2011526805A (ja) | 2011-10-20 |
| US20090324691A1 (en) | 2009-12-31 |
| RU2011103173A (ru) | 2012-08-10 |
| EP2317976A1 (en) | 2011-05-11 |
| CA2729077A1 (en) | 2010-01-07 |
| AU2009265021A1 (en) | 2010-01-07 |
| CN102137654A (zh) | 2011-07-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR072399A1 (es) | Metodos y dispositivos oftalmicos utilizados en el tratamiento de alergias oculares | |
| AR121843A2 (es) | Formulación oftálmica y método para mejorar la presbicia | |
| CO6751277A2 (es) | Anticuerpos humanos frente a pcsk9 para su uso en métodos de tratamiento de grupos concretos de pacientes | |
| ES2537539T3 (es) | Composición oftálmica | |
| CY1115912T1 (el) | Μειωση ενδοφθαλμιας πιεσης με ενδοθαλαμικα εμφυτευματα βηματοπροστης | |
| HK1153636A1 (en) | Ophthalmic devices for the controlled release of active agents | |
| ITVA20110027A1 (it) | Composizioni per la cura della persona | |
| CL2012001583A1 (es) | Preparación oftálmica que comprende: a) povidona yodada, b) un agente refrescante y c) uno o más entre alcanfor, borneol, lubricante, emoliente, antiinflamatorio esteroidal y antinflamatorio no esteroidal; y su uso para el tratamiento y/o profilaxis de un trastorno ocular o una infección. | |
| CL2011000916A1 (es) | Uso de una combinacion de un inhibidor de proteasoma epoxicetona peptidica o una sal farmaceutica aceptable del mismo, y uno o mas de otros agentes terapeuticos para tratar el cancer. | |
| AR059928A1 (es) | Metodos y dispositivos oftalmicos usados en el tratamiento de alergias oculares | |
| EA200901211A1 (ru) | Антигены белка с5 и их применение | |
| UY30254A1 (es) | Tratamientos para la alergia ocular | |
| CL2013001914A1 (es) | Metodo para determinar el potencial miopico de un paciente; metodo para diagnosticar la susceptibilidad de un paciente a un trastorno relacionado con la longitud ocular; metodo para tratar un trastorno relacionado con la longitud ocular; y kit. | |
| CR20110608A (es) | Derivados de 1h-imidazo-[4,5-c]-quinolinona | |
| CL2010001406A1 (es) | Composicion farmaceutica oftalmica que comprende povidona yodada, y un compuesto antiinflamatorio esteroidal, un compuesto antiinflamatorio no esteroidal, un antibacteriano, un antialergico o un compuesto antiglaucoma; y metodo para preservar la composicion. | |
| AR049844A1 (es) | Memantina como tratamiento adyuvante con antipsicoticos atipicos en pacientes con esquizofrenia | |
| BR112015022161A2 (pt) | implante intraocular contendo prostamida | |
| NI200800175A (es) | Uso de derivados de sulfamidas heterocíclicas benzo-fusionadas para el tratamiento de abuso y adicción de sustancias. | |
| AR088585A1 (es) | Un medicamento para tratar la enfermedad del ojo anterior | |
| AR063538A1 (es) | Tratamiento de la enfermedad de parkinson | |
| BRPI0406880A (pt) | Dispositivo de liberação sustentada e método para a liberação ocular de inibidores de anidrase carbÈnicos | |
| WO2011059834A3 (en) | Limited use, self-destructive contact lens case | |
| AR097997A1 (es) | Composición farmaceutica de ibuprofeno y tramadol para uso oftálmico | |
| AR077951A1 (es) | Unidad dispensadora de lentes, metodo y soluciones oftalmicas | |
| CL2009000986A1 (es) | Uso de inhibidores de pai-1 para la p0reparacion de un medicamento util en el tratamiento de hipertension ocular y glaucoma |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |